Medical Condition News

RSS

Researchers receive federal grant to evaluate potential imaging biomarker for Alzheimer's

Researchers at Wake Forest School of Medicine have received a five-year grant worth approximately $2.53 million from the National Institute on Aging to evaluate whether a novel brain-imaging technique can identify Alzheimer's disease in its early stages.

9 Feb 2020

Powerful vaccine could boost the effectiveness of cancer immunotherapy

Supercharging the mutation rate in cancer cells can create a powerful vaccine that is able to boost the effectiveness of immunotherapy, a major new study reports.

9 Feb 2020

Acute Cardiovascular Care 2020 will highlight novel research on recovery from heart emergencies

Innovative research in the diagnosis and treatment of heart emergencies will be revealed at Acute Cardiovascular Care 2020, a scientific congress of the European Society of Cardiology.

9 Feb 2020

Novel method to monitor residual disease after treatment in high-risk neuroblastoma patients

A research group led by Professor NISHIMURA Noriyuki (Graduate School of Health Sciences, Kobe University) has developed a new method to monitor the residual disease after treatment in high-risk neuroblastoma patients.

9 Feb 2020

New therapeutic strategy for lung cancer and associated secondary tumors

In 20 - 40% of patients with cancer, metastasis (the development of secondary tumors) in the central nervous system (CNS) occurs. CNS metastatis impacts negatively on a patient's quality of life, and is associated with a poor health prognosis.

8 Feb 2020

Scientists identify new biomarker for identifying individuals at risk of depression

Chronic pain, or inflammation, is believed to be one of the major factors in the onset of major depressive disorder.

8 Feb 2020

Researchers offer new hope for diagnosis, treatment of age-related macular degeneration

Researchers have identified a new protein linked to age-related macular degeneration (AMD) that could offer new hope for the diagnosis and treatment of the disease, which affects over 1.5 million people in the UK alone.

8 Feb 2020

New gene therapy improves vision in blind mice

Mice born blind have shown significant improvement in vision after undergoing a new gene therapy developed by a team of Japanese scientists.

7 Feb 2020

Automatic method to assess severity of myoclonic jerks from video footage

Fast, reliable and automatic assessment of the severity of myoclonic jerks from video footage is now possible, thanks to an algorithm using deep convolutional neural network architecture and pretrained models that identify and track key points in the human body.

7 Feb 2020

Study: Smartphone apps for skin cancer diagnosis are poorly regulated and unreliable

Smartphone apps used as ‘early warning systems’ for skin cancer are poorly regulated and frequently cannot be relied upon to produce accurate results, according to new analysis by experts at the University of Birmingham.

7 Feb 2020

Gene therapy approach could pave the way for treatment of Stargardt disease

A leading Professor of Ophthalmology at the University of Oxford has shared the details of his research which could pave the way for a new treatment for sight loss condition Stargardt disease.

7 Feb 2020

Researchers discover new approach to make tumors sensitive to immunotherapy

A cancer tumor's ability to mutate allows it to escape from chemotherapy and other attempts to kill it. So, encouraging mutations would not be a logical path for cancer researchers.

7 Feb 2020

Increasing the number of small blood vessels may be helpful for recovering movement

Many health conditions - ranging from disease of particular organs such as heart and lungs, widespread metabolic issues such as diabetes, or following trauma such as spinal cord injury – cause difficulties with movement.

6 Feb 2020

CD19 CAR NK cell therapy clinical trial shows encouraging results for hematologic cancers

According to results from a Phase I/IIa trial at The University of Texas MD Anderson Cancer Center, treatment with cord blood-derived chimeric antigen receptor natural killer (NK)-cell therapy targeting CD19 resulted in clinical responses in a majority of patients with relapsed or refractory non-Hodgkin's lymphoma and chronic lymphocytic leukemia, with no major toxicities observed.

6 Feb 2020

Study identifies two possible targets to halt liver damage in NASH

As much as 12 percent of adults in the United States are living with nonalcoholic steatohepatitis (NASH), an aggressive condition that can lead to cirrhosis or liver cancer.

6 Feb 2020

Cedars-Sinai researchers to study role of fat in promoting cancer spread to liver

A diagnosis of pancreatic or colon cancer often sparks dread about the disease's likely next destination: the liver. That's because liver metastasis is a leading cause of death in these patients.

6 Feb 2020

Online version of MBCT for lingering depression symptoms improves access to care

An online version of a pioneering therapy aimed at reducing the lingering symptoms of depression can offer additional benefits for patients receiving care, according to a new U of T Scarborough study.

6 Feb 2020

Purdue-developed 'fluorescent markers' begin Phase 3 clinical trials

On Target Laboratories Inc., a privately held biotechnology company developing the use of Purdue University-discovered fluorescent markers to target and illuminate cancer during surgery, has announced the results of a multi-institutional Phase 2 clinical trial in which outcomes were improved for 26% of patients undergoing pulmonary resection for non-small-cell lung cancer.

6 Feb 2020

New treatment approach for eosinophilic chronic rhinosinusitis

Eosinophilic chronic rhinosinusitis is a type of airway disease involving nasal inflammation. Many studies have attempted to understand the molecular-based pathogenesis of recurrent ECRS; none have provided a clear explanation, until now.

6 Feb 2020

Missing doctor's visit linked to decreased visual acuity for patients with AMD

Missing a single ophthalmology appointment over a two-year period was associated with decreased visual acuity for patients with macular degeneration -- a leading cause of permanent vision loss in the elderly -- according to a new Penn Medicine study.

6 Feb 2020

Medical Condition News

Researchers receive federal grant to evaluate potential imaging biomarker for Alzheimer's

Powerful vaccine could boost the effectiveness of cancer immunotherapy

Acute Cardiovascular Care 2020 will highlight novel research on recovery from heart emergencies

Novel method to monitor residual disease after treatment in high-risk neuroblastoma patients

New therapeutic strategy for lung cancer and associated secondary tumors

Scientists identify new biomarker for identifying individuals at risk of depression

Researchers offer new hope for diagnosis, treatment of age-related macular degeneration

New gene therapy improves vision in blind mice

Automatic method to assess severity of myoclonic jerks from video footage

Study: Smartphone apps for skin cancer diagnosis are poorly regulated and unreliable

Gene therapy approach could pave the way for treatment of Stargardt disease

Researchers discover new approach to make tumors sensitive to immunotherapy

Increasing the number of small blood vessels may be helpful for recovering movement

CD19 CAR NK cell therapy clinical trial shows encouraging results for hematologic cancers

Study identifies two possible targets to halt liver damage in NASH

Cedars-Sinai researchers to study role of fat in promoting cancer spread to liver

Online version of MBCT for lingering depression symptoms improves access to care

Purdue-developed 'fluorescent markers' begin Phase 3 clinical trials

New treatment approach for eosinophilic chronic rhinosinusitis

Missing doctor's visit linked to decreased visual acuity for patients with AMD

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Latest News